Index -
P/E 125.84
EPS (ttm) 0.66
Insider Own 17.08%
Shs Outstand 113.91M
Perf Week 10.37%
Market Cap 11.36B
Forward P/E 24.39
EPS next Y 3.42
Insider Trans -0.93%
Shs Float 112.91M
Perf Month 17.18%
Income 91.51M
PEG 8.94
EPS next Q 0.74
Inst Own 83.40%
Short Float 2.53%
Perf Quarter 24.36%
Sales 2.48B
P/S 4.58
EPS this Y 28.13%
Inst Trans -0.19%
Short Ratio 3.42
Perf Half Y 32.75%
Book/sh 29.94
P/B 2.79
EPS next Y 15.07%
ROA 1.75%
Short Interest 2.86M
Perf Year 88.90%
Cash/sh 5.10
P/C 16.35
EPS next 5Y 14.07%
ROE 2.22%
52W Range 43.68 - 84.87
Perf YTD 56.54%
Dividend Est. -
P/FCF 38.67
EPS past 5Y -7.04%
ROI 2.20%
52W High -1.71%
Beta 1.18
Dividend TTM -
Quick Ratio 1.64
Sales past 5Y 18.43%
Gross Margin 53.40%
52W Low 90.98%
ATR (14) 2.00
Dividend Ex-Date -
Current Ratio 2.51
EPS Y/Y TTM -57.22%
Oper. Margin 7.31%
RSI (14) 74.76
Volatility 2.90% 2.30%
Employees 5000
Debt/Eq 0.13
Sales Y/Y TTM 102.10%
Profit Margin 3.69%
Recom 1.94
Target Price 90.54
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q 4214.94%
Payout 0.00%
Rel Volume 1.69
Prev Close 81.99
Sales Surprise 3.48%
EPS Surprise 28.26%
Sales Q/Q 63.10%
Earnings Nov 05 AMC
Avg Volume 836.17K
Price 83.42
SMA20 9.59%
SMA50 14.76%
SMA200 30.08%
Trades
Volume 1,444,116
Change 1.74%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-07-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$60 → $78
May-20-24 Upgrade
Piper Sandler
Neutral → Overweight
$60 → $80
Mar-18-24 Upgrade
BTIG Research
Neutral → Buy
$60
Oct-20-23 Initiated
ROTH MKM
Buy
$75
Sep-19-23 Upgrade
Stifel
Hold → Buy
$61
Mar-30-23 Upgrade
Canaccord Genuity
Hold → Buy
$67
Feb-13-23 Downgrade
BofA Securities
Buy → Underperform
$83 → $63
Feb-10-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$67
Feb-10-23 Downgrade
Truist
Buy → Hold
$85 → $70
Feb-10-23 Downgrade
Needham
Buy → Hold
Feb-10-23 Downgrade
Loop Capital
Buy → Hold
$90 → $70
Feb-10-23 Downgrade
BTIG Research
Buy → Neutral
Oct-18-22 Initiated
Barclays
Overweight
$69
Oct-12-22 Initiated
Jefferies
Buy
$75
Apr-13-22 Resumed
Truist
Buy
$80 → $91
Mar-28-22 Initiated
Wells Fargo
Overweight
$80
Jan-04-22 Upgrade
Piper Sandler
Neutral → Overweight
$80 → $88
Dec-13-21 Upgrade
BofA Securities
Underperform → Buy
$55 → $80
Dec-10-21 Initiated
RBC Capital Mkts
Outperform
$80
Oct-29-21 Initiated
Loop Capital
Buy
$100
Show Previous Ratings
Nov-12-24 06:50AM
Nov-11-24 09:45AM
Nov-06-24 07:36AM
(Thomson Reuters StreetEvents) +9.43%
02:21AM
12:07AM
09:15PM
Loading…
Nov-05-24 09:15PM
06:00PM
05:25PM
04:33PM
(Associated Press Finance)
04:15PM
Nov-03-24 01:38PM
Oct-31-24 09:15AM
Oct-18-24 04:30PM
Oct-15-24 04:30PM
07:37AM
04:15PM
Loading…
Oct-02-24 04:15PM
Sep-09-24 09:00PM
Sep-05-24 11:31AM
Aug-30-24 09:00PM
Aug-22-24 08:15AM
05:52AM
Aug-21-24 04:15PM
Aug-14-24 08:12AM
Aug-09-24 09:50AM
Aug-08-24 09:45AM
Aug-07-24 10:26AM
09:50AM
(Thomson Reuters StreetEvents)
Aug-06-24 09:45PM
06:00PM
05:40PM
04:34PM
Loading…
04:34PM
(Associated Press Finance)
04:15PM
Aug-05-24 09:16AM
Jul-19-24 10:37AM
Jul-18-24 09:34AM
04:52AM
Jul-17-24 08:30AM
Jul-16-24 04:30PM
Jul-12-24 09:45AM
09:15AM
Jul-10-24 09:40AM
Jun-20-24 07:13AM
Jun-17-24 09:50AM
Jun-14-24 09:45AM
Jun-06-24 11:31AM
May-31-24 09:50AM
09:29AM
May-23-24 08:51AM
May-20-24 09:31AM
06:59AM
May-15-24 09:50AM
May-14-24 05:24PM
May-13-24 07:07AM
May-10-24 04:52PM
May-09-24 11:57AM
09:15AM
07:58AM
May-08-24 12:39PM
11:32AM
11:00AM
10:33AM
09:40AM
08:52AM
07:24AM
12:45AM
May-07-24 06:00PM
05:38PM
05:30PM
04:32PM
(Associated Press Finance)
04:15PM
May-06-24 09:15AM
Apr-16-24 04:30PM
Apr-15-24 09:50AM
Apr-04-24 08:41AM
Mar-24-24 03:50PM
Mar-21-24 11:30AM
Mar-13-24 04:30PM
12:01PM
Feb-27-24 09:40AM
Feb-26-24 09:50AM
Feb-22-24 03:55AM
Feb-21-24 11:45AM
(Thomson Reuters StreetEvents)
09:45AM
07:13AM
Feb-20-24 08:30PM
07:00PM
05:30PM
04:54PM
04:40PM
(Associated Press Finance)
04:15PM
Feb-14-24 09:15AM
Feb-13-24 05:17PM
10:00AM
Feb-07-24 05:40AM
Feb-05-24 04:30PM
Jan-26-24 06:04AM
Jan-24-24 12:10PM
Jan-23-24 08:42AM
Jan-14-24 12:54PM
Jan-10-24 04:30PM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Scavilla Daniel T President, CEO Nov 06 '24 Option Exercise 35.02 60,000 2,101,200 60,000 Nov 08 04:23 PM Scavilla Daniel T President, CEO Nov 06 '24 Sale 80.02 60,000 4,801,200 0 Nov 08 04:23 PM Huller Kelly SVP, GC, Corporate Secretary Nov 06 '24 Option Exercise 24.21 5,000 121,050 5,000 Nov 08 04:21 PM Huller Kelly SVP, GC, Corporate Secretary Nov 06 '24 Sale 81.01 5,000 405,050 0 Nov 08 04:21 PM Scavilla Daniel T Officer Nov 06 '24 Proposed Sale 79.97 60,000 4,798,000 Nov 06 03:41 PM Huller Kelly Officer Nov 06 '24 Proposed Sale 81.00 5,000 405,000 Nov 06 03:25 PM Huller Kelly SVP, GC, Corporate Secretary Oct 16 '24 Option Exercise 25.80 7,500 193,500 7,500 Oct 18 04:39 PM Davidar David D Director Oct 16 '24 Sale 75.04 30,000 2,251,203 536,275 Oct 18 04:23 PM Davidar David D Director Oct 16 '24 Sale 75.03 20,000 1,500,610 185,967 Oct 18 04:23 PM Huller Kelly Officer Oct 16 '24 Proposed Sale 74.97 7,500 562,250 Oct 16 03:46 PM Davidar David D Director Oct 16 '24 Proposed Sale 74.96 3,500 262,350 Oct 16 03:41 PM Davidar David D Director Oct 16 '24 Proposed Sale 75.00 20,000 1,500,000 Oct 16 03:33 PM Davidar David D Director Oct 16 '24 Proposed Sale 75.00 30,000 2,250,000 Oct 16 03:22 PM RHOADS ANN D Director Sep 13 '24 Option Exercise 24.91 35,000 871,900 57,884 Sep 17 04:34 PM RHOADS ANN D Director Sep 13 '24 Sale 70.36 15,000 1,055,400 42,884 Sep 17 04:34 PM Davidar David D Director Sep 13 '24 Option Exercise 25.52 25,000 638,000 591,275 Sep 17 04:31 PM Davidar David D Director Sep 13 '24 Sale 70.46 25,000 1,761,500 566,275 Sep 17 04:31 PM RHOADS ANN D Director Sep 13 '24 Proposed Sale 70.33 15,000 1,055,000 Sep 13 04:03 PM Davidar David D Director Sep 13 '24 Proposed Sale 70.47 25,000 1,761,780 Sep 13 03:55 PM Norwalk Leslie V Director Jul 11 '24 Sale 70.00 1,000 70,000 16,419 Jul 15 04:25 PM Lemaitre Dan Director May 10 '24 Option Exercise 46.87 52,500 2,460,850 63,300 May 14 05:16 PM Lemaitre Dan Director May 10 '24 Sale 64.61 63,300 4,090,022 0 May 14 05:16 PM Davidar David D Director May 08 '24 Sale 65.00 20,000 1,300,000 566,275 May 10 04:48 PM Norwalk Leslie V Director Mar 15 '24 Sale 51.99 10,590 550,574 17,419 Mar 19 07:40 PM Huller Kelly SVP, GC, Corporate Secretary Mar 01 '24 Option Exercise 24.90 7,500 186,750 7,500 Mar 05 05:07 PM Huller Kelly SVP, GC, Corporate Secretary Mar 01 '24 Sale 54.10 7,500 405,730 0 Mar 05 05:07 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite